Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Oct. 6, 1997

Neutralase proceeds to phase III trials

Oct. 3, 1997

Cor Therapeutics submits NDA amendment for Integrilin to FDA

Oct. 2, 1997

Clinical results presented for Knoll's PEG-hirudin

Sep. 30, 1997

SKB reports new antiplatelet agents

Sep. 29, 1997

Astra describes prodrugs of thrombin inhibitors

Sep. 26, 1997

rNAPc2 completes phase Ia testing with positive results

Sep. 25, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

TP-9201 as adjunct to thrombolysis in stroke

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026